Abstract:Author(s): Fares-Frederickson, Nancy | Advisor(s): David, Michael | Abstract: Interferon regulatory factor 3 (IRF3) is a transcription factor found in the cytoplasm of most nucleated cells. Upon pathogen detection by pattern recognition receptors, IRF3 becomes activated and translocates to the nucleus where it mediates the production of type I interferon (IFN) and IFN-stimulated genes. The collective actions of these genes induce an antimicrobial state within infected and neighboring cells, allowing for pathogen clearance. Whereas the type I IFN system has been studied extensively in the context of pathogen responses, it has more recently become appreciated for its role in immune cell modulation. In this report we discuss novel findings highlighting the involvement of the type I IFN system—with a focus on IRF3—in T cell development, activation, differentiation, and cytokine production.Using a combination of in vitro assays and in vivo disease models, we demonstrate that IRF3 is a positive regulator of lL-17 and IFN-γ in CD4+ T cells. We show that IRF3-deficient CD4+ T cells have impaired production of the pro-inflammatory cytokines IL-17 and IFN-γ, and are unable to induce disease in the T cell transfer model of colitis. Unexpectedly, we observed IRF3 nuclear translocation in activated T cells. To our knowledge, this is the first description of IRF3 activation following T cell receptor stimulation. These results, which are the focus of chapter 1, reveal a previously unappreciated role for IRF3 in CD4+ T cell responses and extend its role beyond the innate immune response to pathogens.Additionally, we show that type I IFN limits T cell production of IL-2—a cytokine required for T cell activation and expansion—by indirectly altering histone modifications in the IL-2 promoter to retain the locus in an inaccessible configuration. These results, which are the focus of chapter 2, help explain why type I IFN has been an effective treatment for multiple sclerosis—a T cell- mediated autoimmune condition.

Beyond innate immunity: the role of interferon regulatory factor 3 in CD4+ T cell function (IRM15P.462)

Beyond Innate Immunity: Defining a Role for Interferon Regulatory Factor 3 in CD4+ T Cell Responses

TRAF3 regulates the effector function of regulatory T cells and humoral immune responses.

Revisiting the role of IRF3 in inflammation and immunity by conditional and specifically targeted gene ablation in mice

Elucidating the contribution of IRF3 to effector and memory cytotoxic T cell responses after influenza virus infection

IRF3 inhibits IFN‐γ‐mediated restriction of intracellular pathogens in macrophages independently of IFNAR

Author Correction: IRF3 Prevents Colorectal Tumorigenesis Via Inhibiting the Nuclear Translocation of Β-Catenin

Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer’s disease

Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling.

Characterization of a Novel Isoform of Murine Interferon Regulatory Factor 3

IRF4 Expression Is Required for the Immunoregulatory Activity of Conventional Type 2 Dendritic Cells in Settings of Chronic Bacterial Infection and Cancer

TRAF3 enhances type I interferon (IFN I) receptor signaling in T cells through modulation of the phosphatase PTPN22

Identification of Novel Alternative Splicing Variants of Interferon Regulatory Factor 3.

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease

IRF5 mediates adaptive immunity via altered glutamine metabolism, mTORC1 signaling and post-transcriptional regulation following T cell receptor activation

Regulating IRFs in IFN Driven Disease

Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.

Cell Type-Specific Function of TRAF2 and TRAF3 in Regulating Type I IFN Induction

IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors